Sep 12, 2025 18:46
CURX - Curanex Pharmaceuticals Inc Common Stock
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 0.42 -0.02 (-3.66%) | 0.0 (0.0%) | 0.0 (0.0%) | 0.0 (0.54%) | 0.0 (-0.17%) | 0.01 (1.3%) | -0.01 (-1.96%) | -0.01 (-1.94%) |
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Market
Earnings & Ratios
- Basic EPS:
- Diluted EPS:
- Basic P/E:
- Diluted P/E:
- RSI(14) 1m:
- 57.14
- VWAP:
- 0.41
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|
Related News
Aug 27, 2025 21:00